Resverlogix Corp. (TSE:RVX – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 31600 shares trading hands. The stock had previously closed at C$0.09.
Resverlogix Price Performance
The company has a quick ratio of 0.04, a current ratio of 0.04 and a debt-to-equity ratio of -82.47. The stock has a market cap of C$30.99 million, a price-to-earnings ratio of -2.25 and a beta of 0.12. The company has a 50 day simple moving average of C$0.10 and a 200-day simple moving average of C$0.10.
About Resverlogix
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.
Further Reading
- Five stocks we like better than Resverlogix
- 3 Energy ETFs Built for Oil’s New $100-Plus Reality
- Can Marvell Keep Up in the Custom AI Chip Race?
- DraftKings Falls 7.6%: Is Kalshi’s NFL Lead Really That Big?
- Gaming Your Portfolio: Should You Add Take-Two Ahead of GTA 6’s November Launch?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
